在非小细胞肺癌中miR-200家族的诊断价值:元分析
1Graduate School, Anhui University of Chinese Medicine, Hefei, 230012, Anhui, China.
Biomarkers in medicine
|July 23, 2024
概括
在早期非小细胞肺癌 (NSCLC) 检测方面,miR-200家族显得有前途,特别是在血液样本中. 这种微RNA组可以帮助区分NSCLC和良性肺部疾病.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物标志物发现发现
背景情况:
- 非小细胞肺癌 (NSCLC) 仍然是全球癌症死亡的主要原因.
- 早期检测对于改善患者的治疗结果和治疗疗效至关重要.
- 需要新的生物标志物来准确和非侵入性诊断NSCLC.
研究的目的:
- 评估miR-200家族用于早期检测NSCLC的诊断能力.
- 评估miR-200家族成员作为NSCLC生物标志物的敏感性和特异性.
- 探索血液中的循环miR-200家族成员在NSCLC诊断中的潜力.
主要方法:
- 进行了系统的文献综述和元分析.
- 研究通过对PubMed,Embase和Web of Science数据库的全面搜索来确定研究.
- 包括20个队列的16项研究被纳入分析了NSCLC中miR-200家族的诊断性能.
主要成果:
- 综合分析表明,在NSCLC检测中,miR-200家族的灵敏度为73%,特异性为85% (AUC=0.83).
- miR-200b表现出异质性,而miR-200a和miR-141表现出更高的敏感性.
- 与其他样本类型相比,血源微RNAs (miRNAs) 的诊断准确性略低.
结论:
- 作为早期NSCLC的诊断生物标志物,miR-200家族具有显著的潜力.
- 循环的miR-200成员,特别是在血液中评估时,为非侵入性NSCLC诊断提供了一个有希望的途径.
- miR-200家族可以帮助区分NSCLC和良性肺部疾病,支持临床决策.
相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K


